{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:55:34Z","timestamp":1792749334623,"version":"4.5.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T00:00:00Z","timestamp":1529971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1038\/s41375-018-0178-x","type":"journal-article","created":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T09:56:58Z","timestamp":1530007018000},"page":"132-147","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":157,"title":["Epstein\u2212Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas"],"prefix":"10.1038","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0212-6734","authenticated-orcid":false,"given":"Eleni","family":"Anastasiadou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Stroopinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Alimperti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan L","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athalia R","family":"Pyzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Cippitelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Pepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Severa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacalyn","family":"Rosenblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilena P","family":"Etna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Rieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Kempkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana M","family":"Coccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannan J Ho","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Uccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Avigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Faggioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8263-0409","authenticated-orcid":false,"given":"Frank J","family":"Slack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,26]]},"reference":[{"key":"178_CR1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrc2542","volume":"9","author":"R Kuppers","year":"2009","unstructured":"Kuppers R. The biology of Hodgkin\u2019s lymphoma. Nat Rev Cancer. 2009;9:15\u201327.","journal-title":"Nat Rev Cancer"},{"key":"178_CR2","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1111\/j.1349-7006.2000.tb00909.x","volume":"91","author":"T Kuze","year":"2000","unstructured":"Kuze T, Nakamura N, Hashimoto Y, Sasaki Y, Abe M. The characteristics of Epstein\u2212Barr virus (EBV)-positive diffuse large B-cell lymphoma: comparison between EBV(+) and EBV(\u2212) cases in Japanese population. Jpn J Cancer Res: Gann. 2000;91:1233\u201340.","journal-title":"Jpn J Cancer Res: Gann"},{"key":"178_CR3","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nrc.2016.92","volume":"16","author":"LS Young","year":"2016","unstructured":"Young LS, Yap LF, Murray PG. Epstein\u2212Barr virus: more than 50 years old and still providing surprises. Nat Rev Cancer. 2016;16:789\u2013802.","journal-title":"Nat Rev Cancer"},{"key":"178_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2014.84","volume":"47","author":"MS Kang","year":"2015","unstructured":"Kang MS, Kieff E. Epstein\u2212Barr virus latent genes. Exp Mol Med. 2015;47:e131.","journal-title":"Exp Mol Med"},{"key":"178_CR5","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S1074-7613(00)00049-2","volume":"13","author":"GJ Babcock","year":"2000","unstructured":"Babcock GJ, Hochberg D, Thorley-Lawson AD. The expression pattern of Epstein\u2212Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity. 2000;13:497\u2013506.","journal-title":"Immunity"},{"key":"178_CR6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.semcancer.2009.07.004","volume":"19","author":"M Rowe","year":"2009","unstructured":"Rowe M, Kelly GL, Bell AI, Rickinson AB. Burkitt\u2019s lymphoma: the Rosetta Stone deciphering Epstein\u2212Barr virus biology. Semin Cancer Biol. 2009;19:377\u201388.","journal-title":"Semin Cancer Biol"},{"issue":"Pt 1","key":"178_CR7","first-page":"17","volume":"390","author":"G Klein","year":"2015","unstructured":"Klein G. Tumor Associations of EBV\u2014historical Perspectives. Curr Top Microbiol Immunol. 2015;390(Pt 1):17\u201322.","journal-title":"Curr Top Microbiol Immunol"},{"key":"178_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11926-015-0552-x","volume":"18","author":"A Farina","year":"2016","unstructured":"Farina A, Farina GA. Fresh insights into disease etiology and the role of microbial pathogens. Curr Rheumatol Rep. 2016;18:1.","journal-title":"Curr Rheumatol Rep"},{"key":"178_CR9","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1128\/JVI.44.3.834-844.1982","volume":"44","author":"M Rabson","year":"1982","unstructured":"Rabson M, Gradoville L, Heston L, Miller G. Non-immortalizing P3J-HR-1 Epstein\u2212Barr virus: a deletion mutant of its transforming parent, Jijoye. J Virol. 1982;44:834\u201344.","journal-title":"J Virol"},{"key":"178_CR10","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.chom.2010.11.004","volume":"8","author":"PA Nikitin","year":"2010","unstructured":"Nikitin PA, Yan CM, Forte E, Bocedi A, Tourigny JP, White RE, et al. An ATM\/Chk2-mediated DNA damage-responsive signaling pathway suppresses Epstein\u2212Barr virus transformation of primary human B cells. Cell Host Microbe. 2010;8:510\u201322.","journal-title":"Cell Host Microbe"},{"key":"178_CR11","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1128\/JVI.65.8.4101-4106.1991","volume":"65","author":"F Wang","year":"1991","unstructured":"Wang F, Kikutani H, Tsang SF, Kishimoto T, Kieff E. Epstein\u2212Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element. J Virol. 1991;65:4101\u20136.","journal-title":"J Virol"},{"key":"178_CR12","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.1128\/JVI.73.5.4481-4484.1999","volume":"73","author":"C Kaiser","year":"1999","unstructured":"Kaiser C, Laux G, Eick D, Jochner N, Bornkamm GW, Kempkes B. The proto-oncogene c-myc is a direct target gene of Epstein\u2212Barr virus nuclear antigen 2. J Virol. 1999;73:4481\u20134.","journal-title":"J Virol"},{"key":"178_CR13","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/j.1460-2075.1996.tb00367.x","volume":"15","author":"N Jochner","year":"1996","unstructured":"Jochner N, Eick D, Zimber-Strobl U, Pawlita M, Bornkamm GW, Kempkes B. Epstein\u2212Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt\u2019s lymphoma cells. EMBO J. 1996;15:375\u201382.","journal-title":"EMBO J"},{"key":"178_CR14","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1128\/JVI.01822-06","volume":"81","author":"F Boccellato","year":"2007","unstructured":"Boccellato F, Anastasiadou E, Rosato P, Kempkes B, Frati L, Faggioni A, et al. EBNA2 interferes with the germinal center phenotype by downregulating BCL6 and TCL1 in non-Hodgkin\u2019s lymphoma cells. J Virol. 2007;81:2274\u201382.","journal-title":"J Virol"},{"key":"178_CR15","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.semcancer.2004.04.018","volume":"14","author":"SD Hayward","year":"2004","unstructured":"Hayward SD. Viral interactions with the Notch pathway. Semin Cancer Biol. 2004;14:387\u201396.","journal-title":"Semin Cancer Biol"},{"key":"178_CR16","doi-asserted-by":"publisher","first-page":"e1005339","DOI":"10.1371\/journal.ppat.1005339","volume":"12","author":"F Lu","year":"2016","unstructured":"Lu F, Chen HS, Kossenkov AV, DeWispeleare K, Won KJ, Lieberman PM. EBNA2 drives formation of new chromosome binding sites and target genes for B-cell master regulatory transcription factors RBP-jkappa and EBF1. PLoS Pathog. 2016;12:e1005339.","journal-title":"PLoS Pathog"},{"key":"178_CR17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1126\/science.8016657","volume":"265","author":"T Henkel","year":"1994","unstructured":"Henkel T, Ling PD, Hayward SD, Peterson MG. Mediation of Epstein\u2212Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa. Science (New Y, NY). 1994;265:92\u20135.","journal-title":"Science (New Y, NY)"},{"key":"178_CR18","doi-asserted-by":"publisher","first-page":"14902","DOI":"10.1073\/pnas.1108892108","volume":"108","author":"B Zhao","year":"2011","unstructured":"Zhao B, Zou J, Wang H, Johannsen E, Peng CW, Quackenbush J, et al. Epstein\u2212Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth. Proc Natl Acad Sci USA. 2011;108:14902\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"178_CR19","doi-asserted-by":"publisher","first-page":"e1006664","DOI":"10.1371\/journal.ppat.1006664","volume":"13","author":"LV Glaser","year":"2017","unstructured":"Glaser LV, Rieger S, Thumann S, Beer S, Kuklik-Roos C, Martin DE, et al. EBF1 binds to EBNA2 and promotes the assembly of EBNA2 chromatin complexes in B cells. PLoS Pathog. 2017;13:e1006664.","journal-title":"PLoS Pathog"},{"key":"178_CR20","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.cell.2015.03.030","volume":"161","author":"P Sharma","year":"2015","unstructured":"Sharma P, Allison JP. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. Cell . 2015;161:205\u201314.","journal-title":"Cell"},{"key":"178_CR21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1126\/science.aaa8172","volume":"348","author":"P Sharma","year":"2015","unstructured":"Sharma P, Allison JP. The future of immune checkpoint therapy. Science (New Y, NY). 2015;348:56\u201361.","journal-title":"Science (New Y, NY)"},{"key":"178_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrc.2017.99","volume":"18","author":"E Anastasiadou","year":"2018","unstructured":"Anastasiadou E, Jacob LS, Slack FJ. Non-coding RNA networks in cancer. Nat Rev Cancer. 2018;18:5\u201318.","journal-title":"Nat Rev Cancer"},{"key":"178_CR23","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nrc3166","volume":"11","author":"AL Kasinski","year":"2011","unstructured":"Kasinski AL, Slack FJ. Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer. 2011;11:849\u201364.","journal-title":"Nat Rev Cancer"},{"key":"178_CR24","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.molcel.2007.05.017","volume":"26","author":"N Raver-Shapira","year":"2007","unstructured":"Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell. 2007;26:731\u201343.","journal-title":"Mol Cell"},{"key":"178_CR25","doi-asserted-by":"publisher","first-page":"5206","DOI":"10.1158\/0008-5472.CAN-15-1989","volume":"75","author":"BD Adams","year":"2015","unstructured":"Adams BD, Anastasiadou E, Esteller M, He L, Slack FJ. The inescapable influence of noncoding RNAs in cancer. Cancer Res. 2015;75:5206\u201310.","journal-title":"Cancer Res"},{"key":"178_CR26","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/cdd.2009.56","volume":"17","author":"H Hermeking","year":"2010","unstructured":"Hermeking H. The miR-34 family in cancer and apoptosis. Cell Death Differ. 2010;17:193\u20139.","journal-title":"Cell Death Differ"},{"key":"178_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-12-52","volume":"12","author":"LQ Wang","year":"2014","unstructured":"Wang LQ, Kwong YL, Wong KF, Kho CS, Jin DY, Tse E, et al. Epigenetic inactivation of mir-34b\/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia. J Transl Med. 2014;12:52.","journal-title":"J Transl Med"},{"key":"178_CR28","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.4161\/cc.9.14.12267","volume":"9","author":"O Merkel","year":"2010","unstructured":"Merkel O, Asslaber D, Pinon JD, Egle A, Greil R. Interdependent regulation of p53 and miR-34a in chronic lymphocytic leukemia. Cell Cycle (Georget, Tex). 2010;9:2764\u20138.","journal-title":"Cell Cycle (Georget, Tex)"},{"key":"178_CR29","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cellsig.2014.12.003","volume":"27","author":"X Wang","year":"2015","unstructured":"Wang X, Li J, Dong K, Lin F, Long M, Ouyang Y, et al. Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia. Cell Signal. 2015;27:443\u201352.","journal-title":"Cell Signal"},{"key":"178_CR30","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503\u201311.","journal-title":"Nature"},{"key":"178_CR31","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1182\/blood-2015-02-629600","volume":"126","author":"J Kiyasu","year":"2015","unstructured":"Kiyasu J, Miyoshi H, Hirata A, Arakawa F, Ichikawa A, Niino D, et al. Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma. Blood. 2015;126:2193\u2013201.","journal-title":"Blood"},{"key":"178_CR32","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/his.12882","volume":"68","author":"D Kwon","year":"2016","unstructured":"Kwon D, Kim S, Kim PJ, Go H, Nam SJ, Paik JH, et al. Clinicopathological analysis of programmed cell death 1 and programmed cell death ligand 1 expression in the tumour microenvironments of diffuse large B cell lymphomas. Histopathology. 2016;68:1079\u201389.","journal-title":"Histopathology"},{"key":"178_CR33","doi-asserted-by":"crossref","first-page":"59976","DOI":"10.18632\/oncotarget.11045","volume":"7","author":"W Xing","year":"2016","unstructured":"Xing W, Dresser K, Zhang R, Evens AM, Yu H, Woda BA, et al. PD-L1 expression in EBV-negative diffuse large B-cell lymphoma: clinicopathologic features and prognostic implications. Oncotarget. 2016;7:59976\u201386.","journal-title":"Oncotarget"},{"key":"178_CR34","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/bjh.14432","volume":"180","author":"A Kwiecinska","year":"2016","unstructured":"Kwiecinska A, Tsesmetzis N, Ghaderi M, Kis L, Saft L, Rassidakis GZ. CD274 (PD-L1)\/PDCD1 (PD-1) expression in de novo and transformed diffuse large B-cell lymphoma. Br J Haematol. 2016;180:744\u20138.","journal-title":"Br J Haematol"},{"key":"178_CR35","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1182\/blood-2007-01-067769","volume":"110","author":"S Park","year":"2007","unstructured":"Park S, Lee J, Ko YH, Han A, Jun HJ, Lee SC, et al. The impact of Epstein\u2212Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood. 2007;110:972\u20138.","journal-title":"Blood"},{"key":"178_CR36","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1158\/2326-6066.CIR-16-0201","volume":"4","author":"MG Roemer","year":"2016","unstructured":"Roemer MG, Advani RH, Redd RA, Pinkus GS, Natkunam Y, Ligon AH, et al. Classical Hodgkin lymphoma with reduced beta2M\/MHC class I expression is associated with inferior outcome independent of 9p24.1 status. Cancer Immunol Res. 2016;4:910\u20136.","journal-title":"Cancer Immunol Res"},{"key":"178_CR37","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1158\/1078-0432.CCR-11-1942","volume":"18","author":"MR Green","year":"2012","unstructured":"Green MR, Rodig S, Juszczynski P, Ouyang J, Sinha P, O\u2019Donnell E, et al. Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy. Clin Cancer Res: Off J Am Assoc Cancer Res. 2012;18:1611\u20138.","journal-title":"Clin Cancer Res: Off J Am Assoc Cancer Res"},{"key":"178_CR38","doi-asserted-by":"crossref","first-page":"12189","DOI":"10.18632\/oncotarget.2608","volume":"5","author":"W Fang","year":"2014","unstructured":"Fang W, Zhang J, Hong S, Zhan J, Chen N, Qin T, et al. EBV-driven LMP1 and IFN-gamma up-regulate PD-L1 in nasopharyngeal carcinoma: implications for oncotargeted therapy. Oncotarget. 2014;5:12189\u2013202.","journal-title":"Oncotarget"},{"key":"178_CR39","first-page":"505","volume":"11","author":"P Trivedi","year":"1995","unstructured":"Trivedi P, Zhang QJ, Chen F, Minarovits J, Ekman M, Biberfeld P, et al. Parallel existence of Epstein\u2212Barr virus (EBV) positive and negative cells in a sporadic case of Burkitt lymphoma. Oncogene. 1995;11:505\u201310.","journal-title":"Oncogene"},{"key":"178_CR40","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/j.1460-2075.1995.tb06978.x","volume":"14","author":"B Kempkes","year":"1995","unstructured":"Kempkes B, Spitkovsky D, Jansen-Durr P, Ellwart JW, Kremmer E, Delecluse HJ, et al. B-cell proliferation and induction of early G1-regulating proteins by Epstein\u2212Barr virus mutants conditional for EBNA2. EMBO J. 1995;14:88\u201396.","journal-title":"EMBO J"},{"key":"178_CR41","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.canlet.2009.04.025","volume":"284","author":"E Anastasiadou","year":"2009","unstructured":"Anastasiadou E, Vaeth S, Cuomo L, Boccellato F, Vincenti S, Cirone M, et al. Epstein\u2013Barr virus infection leads to partial phenotypic reversion of terminally differentiated malignant B cells. Cancer Lett. 2009;284:165\u201374.","journal-title":"Cancer Lett"},{"key":"178_CR42","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1002\/ijc.29489","volume":"137","author":"E Anastasiadou","year":"2015","unstructured":"Anastasiadou E, Garg N, Bigi R, Yadav S, Campese AF, Lapenta C, et al. Epstein\u2212Barr virus infection induces miR-21 in terminally differentiated malignant B cells. Int J Cancer. 2015;137:1491\u20137.","journal-title":"Int J Cancer"},{"key":"178_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-015-0353-1","volume":"12","author":"C Veroni","year":"2015","unstructured":"Veroni C, Marnetto F, Granieri L, Bertolotto A, Ballerini C, Repice AM, et al. Immune and Epstein\u2212Barr virus gene expression in cerebrospinal fluid and peripheral blood mononuclear cells from patients with relapsing-remitting multiple sclerosis. J Neuroinflamm. 2015;12:132.","journal-title":"J Neuroinflamm"},{"key":"178_CR44","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1006\/viro.1995.0084","volume":"214","author":"B Kempkes","year":"1995","unstructured":"Kempkes B, Pawlita M, Zimber-Strobl U, Eissner G, Laux G, Bornkamm GW. Epstein\u2212Barr virus nuclear antigen 2-estrogen receptor fusion proteins transactivate viral and cellular genes and interact with RBP-J kappa in a conditional fashion. Virology. 1995;214:675\u20139.","journal-title":"Virology"},{"key":"178_CR45","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1128\/JVI.72.5.4371-4378.1998","volume":"72","author":"S Imai","year":"1998","unstructured":"Imai S, Nishikawa J, Takada K. Cell-to-cell contact as an efficient mode of Epstein\u2212Barr virus infection of diverse human epithelial cells. J Virol. 1998;72:4371\u20138.","journal-title":"J Virol"},{"key":"178_CR46","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1038\/onc.2009.439","volume":"29","author":"E Anastasiadou","year":"2010","unstructured":"Anastasiadou E, Boccellato F, Vincenti S, Rosato P, Bozzoni I, Frati L, et al. Epstein\u2013Barr virus encoded LMP1 downregulates TCL1 oncogene through miR-29b. Oncogene. 2010;29:1316\u201328.","journal-title":"Oncogene"},{"key":"178_CR47","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1038\/sj.leu.2403895","volume":"19","author":"E Anastasiadou","year":"2005","unstructured":"Anastasiadou E, Boccellato F, Cirone M, Kis LL, Klein E, Frati L, et al. Epigenetic mechanisms do not control viral latency III in primary effusion lymphoma cells infected with a recombinant Epstein\u2013Barr virus. Leukemia. 2005;19:1854\u20136.","journal-title":"Leukemia"},{"key":"178_CR48","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1002\/pbc.24654","volume":"60","author":"A Napoli Di","year":"2013","unstructured":"Di Napoli A, Al-Jadiri MF, Talerico C, Duranti E, Pilozzi E, Trivedi P, et al. Epstein\u2212Barr virus (EBV) positive classical Hodgkin lymphoma of Iraqi children: an immunophenotypic and molecular characterization of Hodgkin\/Reed-Sternberg cells. Pediatr Blood Cancer. 2013;60:2068\u201372.","journal-title":"Pediatr Blood Cancer"},{"key":"178_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10954","volume":"7","author":"DW Salzman","year":"2016","unstructured":"Salzman DW, Nakamura K, Nallur S, Dookwah MT, Metheetrairut C, Slack FJ, et al. miR-34 activity is modulated through 5\u2019-end phosphorylation in response to DNA damage. Nat Commun. 2016;7:10954.","journal-title":"Nat Commun"},{"key":"178_CR50","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1158\/0008-5472.CAN-15-2321","volume":"76","author":"BD Adams","year":"2016","unstructured":"Adams BD, Wali VB, Cheng CJ, Inukai S, Booth CJ, Agarwal S, et al. miR-34a silences c-SRC to attenuate tumor growth in triple-negative breast cancer. Cancer Res. 2016;76:927\u201339.","journal-title":"Cancer Res"},{"key":"178_CR51","doi-asserted-by":"publisher","first-page":"8758","DOI":"10.1073\/pnas.1618333114","volume":"114","author":"S Alimperti","year":"2017","unstructured":"Alimperti S, Mirabella T, Bajaj V, Polacheck W, Pirone DM, Duffield J, et al. Three-dimensional biomimetic vascular model reveals a RhoA, Rac1, and N-cadherin balance in mural cell-endothelial cell-regulated barrier function. Proc Natl Acad Sci USA. 2017;114:8758\u201363.","journal-title":"Proc Natl Acad Sci USA"},{"key":"178_CR52","doi-asserted-by":"publisher","first-page":"6712","DOI":"10.1073\/pnas.1221526110","volume":"110","author":"DH Nguyen","year":"2013","unstructured":"Nguyen DH, Stapleton SC, Yang MT, Cha SS, Choi CK, Galie PA, et al. Biomimetic model to reconstitute angiogenic sprouting morphogenesis in vitro. Proc Natl Acad Sci USA. 2013;110:6712\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"178_CR53","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.1128\/JVI.75.10.4929-4935.2001","volume":"75","author":"P Trivedi","year":"2001","unstructured":"Trivedi P, Spinsanti P, Cuomo L, Volpe M, Takada K, Frati L, et al. Differential regulation of Epstein\u2013Barr virus (EBV) latent gene expression in Burkitt lymphoma cells infected with a recombinant EBV strain. J Virol. 2001;75:4929\u201335.","journal-title":"J Virol"},{"key":"178_CR54","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1038\/leu.2012.108","volume":"26","author":"P Rosato","year":"2012","unstructured":"Rosato P, Anastasiadou E, Garg N, Lenze D, Boccellato F, Vincenti S, et al. Differential regulation of miR-21 and miR-146a by Epstein\u2013Barr virus-encoded EBNA2. Leukemia. 2012;26:2343\u201352.","journal-title":"Leukemia"},{"key":"178_CR55","doi-asserted-by":"publisher","first-page":"5576","DOI":"10.1158\/0008-5472.CAN-12-2001","volume":"72","author":"AL Kasinski","year":"2012","unstructured":"Kasinski AL, Slack FJ. miRNA-34 prevents cancer initiation and progression in a therapeutically resistant K-ras and p53-induced mouse model of lung adenocarcinoma. Cancer Res. 2012;72:5576\u201387.","journal-title":"Cancer Res"},{"key":"178_CR56","doi-asserted-by":"crossref","unstructured":"Khan A, Fornes O, Stigliani A, Gheorghe M, Castro-Mondragon JA, van der Lee R, et al. JASPAR 2018: update of the open-access database of transcription factor binding profiles and its web framework. Nucleic Acids Res. 2018;46:D260\u2013D266.","DOI":"10.1093\/nar\/gkx1126"},{"key":"178_CR57","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbs017","volume":"14","author":"H Thorvaldsdottir","year":"2013","unstructured":"Thorvaldsdottir H, Robinson JT, Mesirov JP. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform. 2013;14:178\u201392.","journal-title":"Brief Bioinform"},{"key":"178_CR58","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1126\/science.280.5361.248","volume":"280","author":"HL Ploegh","year":"1998","unstructured":"Ploegh HL. Viral strategies of immune evasion. Science (New Y, NY). 1998;280:248\u201353.","journal-title":"Science (New Y, NY)"},{"key":"178_CR59","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1177\/117693510700300004","volume":"3","author":"S Blenk","year":"2007","unstructured":"Blenk S, Engelmann J, Weniger M, Schultz J, Dittrich M, Rosenwald A, et al. Germinal center B cell-like (GCB) and activated B cell-like (ABC) type of diffuse large B cell lymphoma (DLBCL): analysis of molecular predictors, signatures, cell cycle state and patient survival. Cancer Inform. 2007;3:399\u2013420.","journal-title":"Cancer Inform"},{"key":"178_CR60","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3389\/fgene.2012.00120","volume":"3","author":"AG Bader","year":"2012","unstructured":"Bader AG. miR-34\u2014a microRNA replacement therapy is headed to the clinic. Front Genet. 2012;3:120.","journal-title":"Front Genet"},{"key":"178_CR61","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.exphem.2015.12.007","volume":"44","author":"SC Marques","year":"2016","unstructured":"Marques SC,Ranjbar B,Laursen MB,Falgreen S,Bilgrau AE,Bodker JS, et al. High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma. Exp Hematol. 2016;44:238\u201346.e2.","journal-title":"Exp Hematol"},{"key":"178_CR62","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1038\/leu.2012.110","volume":"26","author":"VJ Craig","year":"2012","unstructured":"Craig VJ, Tzankov A, Flori M, Schmid CA, Bader AG, Muller A. Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo. Leukemia. 2012;26:2421\u20134.","journal-title":"Leukemia"},{"key":"178_CR63","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.immuni.2010.06.013","volume":"33","author":"DS Rao","year":"2010","unstructured":"Rao DS, O\u2019Connell RM, Chaudhuri AA, Garcia-Flores Y, Geiger TL, Baltimore D. MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1. Immunity. 2010;33:48\u201359.","journal-title":"Immunity"},{"key":"178_CR64","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1038\/leu.2017.163","volume":"31","author":"AR Pyzer","year":"2017","unstructured":"Pyzer AR, Stroopinsky D, Rosenblatt J, Anastasiadou E, Rajabi H, Washington A, et al. MUC1 inhibition leads to decrease in PD-L1 levels via up-regulation of miRNAs. Leukemia. 2017;31:2780\u201390.","journal-title":"Leukemia"},{"key":"178_CR65","doi-asserted-by":"publisher","first-page":"e01987","DOI":"10.1128\/JVI.01987-16","volume":"91","author":"CK Wille","year":"2017","unstructured":"Wille CK, Li Y, Rui L, Johannsen EC, Kenney SC. Restricted TET2 expression in germinal center type B cells promotes stringent Epstein\u2212Barr virus latency. J Virol. 2017;91:e01987\u201316.","journal-title":"J Virol"},{"key":"178_CR66","doi-asserted-by":"crossref","unstructured":"Lu F, Wiedmer A, Martin KA, Wickramasinghe P, Kossenkov AV, Lieberman PM. Coordinate regulation of TET2 and EBNA2 control DNA methylation state of latent Epstein\u2212Barr virus. J Virol. 2017;91:e00804\u201317.","DOI":"10.1128\/JVI.00804-17"},{"key":"178_CR67","doi-asserted-by":"publisher","first-page":"7569","DOI":"10.1158\/0008-5472.CAN-09-0529","volume":"69","author":"Y Li","year":"2009","unstructured":"Li Y, Guessous F, Zhang Y, Dipierro C, Kefas B, Johnson E, et al. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res. 2009;69:7569\u201376.","journal-title":"Cancer Res"},{"key":"178_CR68","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1093\/carcin\/bgr286","volume":"33","author":"S Yamamura","year":"2012","unstructured":"Yamamura S, Saini S, Majid S, Hirata H, Ueno K, Chang I, et al. MicroRNA-34a suppresses malignant transformation by targeting c-Myc transcriptional complexes in human renal cell carcinoma. Carcinogenesis. 2012;33:294\u2013300.","journal-title":"Carcinogenesis"},{"key":"178_CR69","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1126\/science.aac9935","volume":"352","author":"SC Casey","year":"2016","unstructured":"Casey SC, Tong L, Li Y, Do R, Walz S, Fitzgerald KN, et al. MYC regulates the antitumor immune response through CD47 and PD-L1. Science (New Y, NY). 2016;352:227\u201331.","journal-title":"Science (New Y, NY)"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41375-018-0178-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-018-0178-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-018-0178-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:35:10Z","timestamp":1684618510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-018-0178-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,26]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["178"],"URL":"https:\/\/doi.org\/10.1038\/s41375-018-0178-x","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,26]]},"assertion":[{"value":"28 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}